L. Demirturk et al., CagA status in dyspeptic patients with and without peptic ulcer disease inTurkey: Association with histopathologic findings, HELICOBACT, 6(2), 2001, pp. 163-168
Background. CagA seropositivity is closely associated with that of vacuolat
ing cytotoxin (VacA). Helicobacter pylori strains positive for both VacA an
d CagA were reported to be strongly associated with peptic ulcer disease. D
ifferent results reporting that cagA gene is not associated with more serio
us diseases, lowers the importance of CagA protein as a marker. In this stu
dy, CagA seropositivity is examined in Turkish peptic ulcer and nonulcer dy
spepsia patients; histopathologic scores of CagA (+) and CagA (-) groups we
re compared.
Materials and Methods. Sixty consecutive patients (one gastric ulcer, 13 du
odenal ulcer and 46 nonulcer dyspepsia) (mean age 40.9 +/- 14.7; 33 women,
27 men) with dyspeptic complaints who underwent upper gastrointestinal (GI)
endoscopy were included. Biopsies from the antrum and corpus were used for
histopathologic examination and for rapid urease test. H. pylori-negative
patients comprised the control group. Histopathologic findings were graded
using a previously described grading system (for inflammation, activity atr
ophy, intestinal metaplasia and H. pylori, grades from 0 to 3 were used to
quantify the findings). In H. pylori-positive patients, antibodies against
CagA protein were determined using an ELISA method.
Results. H. pylori was (+) in 46 patients. One duodenal ulcer and 13 nonulc
er dyspepsia patients were negative for H. pylori. CagA positivity is signi
ficantly higher in peptic ulcer patients [12/12] than in nonulcer dyspepsia
patients [25/33]. While inflammation, activity and atrophy scores were sig
nificantly higher in CagA positive patients, intestinal metaplasia and H. p
ylori load scores were not. Although the histopathologic scores in controls
were lower than CagA (-) group, statistical significance was observed only
in inflammation and intestinal metaplasia scores.
Conclusion. Development of more prominent gastritis and severe atrophy in C
agA (+) patients is an indicator of the importance of CagA rather than H. p
ylori load. Therefore, we suggest that nonulcer dyspepsia patients should a
lso be tested for CagA status along with the tests for H. pylori status; an
d a positive CagA testing should be considered as an indication for eradica
tion treatment. If CagA is negative, further assessment should be performed
to decide whether or not to treat the patient.